CD357 (AITR/GITR) Antibody 14-5875-80 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

Flow

Normal human peripheral blood cells were cultured for 3 days with PHA and stained with Mouse IgG1 k Isotype Control Purified (Product # 14-4714-82) (open histogram) or Anti-Human CD357 (AITR) Purified (filled histogram) followed by F (ab')2 Anti-Mouse IgG PE (Product # 12-4012).Total viable cells were used for analysis.
CD357 (AITR/GITR) Antibody

Normal human peripheral blood cells were cultured for 3 days with PHA and stained with Mouse IgG1 k Isotype Control Purified (Product # 14-4714-82) (open histogram) or Anti-Human CD357 (AITR) Purified (filled histogram) followed by F (ab')2 Anti-Mouse IgG PE (Product # 12-4012).Total viable cells were used for analysis.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
CD357 (AITR/GITR) Antibody

The CD357 (AITR/GITR) Antibody from Thermo Fisher Scientific is a Mouse Monoclonal antibody to TNFRSF18. This antibody recognizes Homo Sapiens, and Human antigen. The CD357 (AITR/GITR) Antibody has been shown to work in the following applications: EIA, Immunoassay, ELISA, Flow Cytometry, and Western Blot.

Product Specs
ItemCD357 (AITR/GITR) Antibody
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number14-5875-80
Quantity25 µg
ApplicationsELISA, Flow Cytometry, Western Blot
Concentration0.5 mg/mL
FormatPBS with 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD357 (AITR/GITR)
IsotypeIgG1 kappa
CloneeBioAITR
HostMouse
ClonalityMonoclonal
PurityAffinity chromatography
Conjugate/TagUnconjugated
Storage Temperature4° C
NCBI Full Gene NameTNF receptor superfamily member 18
NCBI Gene AliasesAITR, CD357, ENERGEN, GITR, GITR-D
Storage4°C
Antibody TypePrimary

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patientsBlood advancesJanuary 23, 2018Arruda LCM, Malmegrim KCR, Lima-Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, et al.

(2) CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapyOncotargetNovember 15, 2016Komdeur FL, Wouters MC, Workel HH, Tijans AM, Terwindt AL, Brunekreeft KL, Plat A, Klip HG, Eggink FA, Leffers N, et al.

(3) Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV InfectionPLoS pathogensOctober 1, 2016Miles B, Miller SM, Folkvord JM, Levy DN, Rakasz EG, Skinner PJ, Connick E.

(4) HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individualsRetrovirologyMay 30, 2012Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M.

(5) CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infectionThe Journal of infectious diseasesAugust 15, 2010Green AM, Mattila JT, Bigbee CL, Bongers KS, Lin PL, Flynn JL.

Be the First to Write a Review!